News
D.C. sue to block 23andMe's data sale amid bankruptcy proceedings. Regeneron Pharmaceuticals' $256 million acquisition faces ...
SAN FRANCISCO, June 13, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today announced that it has entered ...
States sue to halt Regeneron's 23andMe acquisition, citing privacy concerns over user DNA data, as a court-ordered report on ...
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
WilmerHale said it’s representing the law professor tapped to make privacy-related recommendations about the sale of ...
Lawmakers want to know what will be done to make sure consumer genetic testing company 23andMe’s data will stay out of the ...
The founder of 23andMe has asked a federal bankruptcy court judge to reopen an auction for the genetic testing company, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results